QGel has validated an innovative process to test drug and improve diagnosis

The rise of organoids could revolutionize the pharmacological research and limit the use of animal testing. QGel, based at the Innovation Park at EPFL, has validated an industrial production process, which is biologically very accurate, of a matrix for large pharmaceutical companies.

The Company features in Le Temps today (May 18, 2016) “Mini-organes au service de la recherche“

And L’Agefi emphasizes the role of Qgel for drug testing and development of better diagnostics

All info about QGel: http://www.qgelbio.com/